A 52-year-old man with a 20-year history of heavy alcohol consumption presents with jaundice, ascites, and hepatic encephalopathy. Liver biopsy confirms cirrhosis with active inflammation. Which drug is the first-line pharmacological agent to reduce mortality in alcoholic cirrhosis with hepatic encephalopathy?

Explanation

## First-Line Management of Hepatic Encephalopathy in Alcoholic Cirrhosis **Key Point:** Lactulose is the gold-standard first-line agent for hepatic encephalopathy in cirrhosis, including alcoholic cirrhosis, with proven mortality benefit and guideline recommendation across major hepatology societies. ### Mechanism of Action Lactulose is a non-absorbable disaccharide that: 1. Reduces colonic pH, converting ammonia (NH₃) to ammonium (NH₄⁺), which is poorly absorbed 2. Acts as an osmotic laxative, reducing transit time and bacterial ammonia production 3. Selectively promotes growth of non-urease-producing bacteria ### Dosing & Efficacy - **Starting dose:** 15–30 mL twice daily, titrated to 2–3 soft stools daily - **Target:** Serum ammonia reduction and clinical improvement in mental status - **Evidence:** Level 1A evidence for mortality reduction in hepatic encephalopathy [cite:Harrison 21e Ch 297] ### Comparison with Other Agents | Agent | Role | Efficacy | First-Line? | |-------|------|---------|-------------| | **Lactulose** | Reduces ammonia absorption | Proven mortality benefit | **YES** | | **Rifaxomicin** | Non-absorbed antibiotic; reduces urease-producing bacteria | Equivalent to lactulose; better tolerability | Second-line or adjunct | | **Neomycin** | Non-absorbed aminoglycoside; reduces bacterial ammonia production | Modest effect; ototoxicity risk | Rarely used now | | **Metronidazole** | Antibiotic; variable ammonia reduction | Inconsistent; not recommended | **NO** | **High-Yield:** Lactulose remains the first-line agent because it has the longest track record of mortality reduction and is universally recommended by AASLD, EASL, and other major guidelines. Rifaxomicin is increasingly used as an adjunct or alternative in patients intolerant to lactulose. **Clinical Pearl:** In acute hepatic encephalopathy, lactulose should be started immediately while investigating precipitants (infection, GI bleed, renal failure, medication changes). Do not wait for ammonia levels — clinical response is the endpoint.